If I could index all experiments ran by companies and if they succeeded or failed could i technically build a world model (how would I do that) to make a baysian experiment platform? Does something like this exist and if so what does it look like?

Claude Opus 4.8

Answer: Indexing company experiments could theoretically enable a Bayesian platform for experiment prediction, but insurmountable data access and standardization barriers prevent a true cross-industry world model from existing today.

The responses from GPT-5.5, Gemini 3.5 Flash, and Grok 4.3 largely align with my prior view, reinforcing that proprietary silos, selection bias, and context-dependence make universal aggregation impractical. Gemini and Grok provide useful technical details on hierarchical Bayesian models and latent embeddings, yet they do not overcome the core obstacles of data availability that I highlighted. No argument presented a viable path to radical data-sharing changes, so I maintain my original stance without attribution to any other model.

Grok 4.3

Answer: After reviewing the other models' responses, I maintain my original position that indexing corporate experiments could enable a Bayesian experimentation platform but not a true world model, due to insurmountable practical barriers like proprietary data and biases.

The responses from Claude Opus 4.8, GPT-5.5, and Gemini 3.5 Flash all reinforce the same core limitations I identified, including selection bias, non-stationarity, and the impossibility of aggregating proprietary company data at scale. None introduce new evidence or arguments that would overcome these structural obstacles or suggest a viable path to a universal cross-company model. Existing partial implementations remain confined to internal tools or narrow domains like clinical trials, consistent with my prior assessment.

Gemini 3.5 Flash

Answer: I maintain my position that a Bayesian experiment platform powered by a global 'world model' is theoretically feasible through empirical priors, but practically constrained by proprietary silos, non-stationarity, and systemic data biases.

There is a strong consensus across all models (Claude, GPT, and Grok) regarding the mathematical feasibility of this platform. Using historical experiments to construct empirical priors for hierarchical Bayesian meta-analysis is a sound framework. However, we all agree that the primary blocker is not the math, but the data: corporate experiments are highly guarded proprietary secrets, and current public analogs like ClinicalTrials.gov do not span the multi-industry commercial space. I agree with Grok 4.3's nuance that calling this a true 'world model' might be an overstatement; it is more accurately described as a 'highly contextual probabilistic meta-predictor.' This is because human behavior and digital ecosystems are highly non-stationary. A UX layout or pricing model that succeeded in 2020 might fail today due to shifting consumer expectations. This temporal decay, combined with severe selection and survivorship biases (since companies rarely document or share their failures systematically), means the 'world model' would have a constantly shifting ground truth. To make this platform a reality without relying on a central, impossible-to-gather repository, one would likely need to employ federated learning with differential privacy. This would allow companies to collaboratively train a shared meta-predictor on their experimental data without exposing their proprietary IP or user metrics. Until such privacy-preserving collaborative frameworks are adopted, these 'world models' will remain restricted to the internal walled gardens of tech giants like Meta, Google, and Netflix.

GPT-5.5

Answer: Indexing successful and failed company experiments could theoretically power a Bayesian world model for predictive experimentation, but building and accessing such a comprehensive dataset faces insurmountable practical barriers today.

The other responses align closely with this assessment by emphasizing that while hierarchical Bayesian models or causal networks could leverage historical data for informed priors and reduced sample sizes, severe issues like proprietary data silos, selection bias, and non-stationarity prevent a universal platform. No model presented evidence of a cross-industry solution emerging, instead reinforcing that existing tools such as Optimizely or internal systems at Meta remain limited to single organizations or specific domains like clinical trials. The consistency across answers confirms that radical changes in data sharing would be required, leaving the core barriers intact.

Final Summary

The AI Roundtable unanimously agreed that while hierarchical Bayesian models could technically construct empirical priors from past experiments, building a universal platform is practically impossible. Claude Opus 4.8, GPT-5.5, and Grok 4.3 emphasized that corporate experiments are highly guarded trade secrets, preventing necessary data aggregation. Gemini 3.5 Flash added that even if data were available, non-stationarity and extreme context-dependence would rapidly decay the model's predictive accuracy.

All 4 models agreed